Es gab 50 kürzliche Insider-Transaktionen für RenovoRx, Inc. (RNXT), darunter 47 Käufe und 1 Verkauf. Die gesamten Insider-Käufe beliefen sich auf $2.11M und die gesamten Insider-Verkäufe auf $3.07K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Voll Mark, Marton Laurence, Bagai Shaun. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — RNXT
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-25 |
Voll Mark |
Chief Financial Officer |
RSU-Zuteilung |
12,380 |
- |
- |
37,380 |
| 2026-03-20 |
Voll Mark |
Chief Financial Officer |
Informierter Kauf |
48,600 |
$1.93 |
$93.92K |
48,600 |
| 2026-03-20 |
Marton Laurence |
Director |
Informierter Kauf |
4,860 |
$1.93 |
$9.39K |
4,860 |
| 2026-03-20 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
12,150 |
$1.93 |
$23.48K |
12,150 |
| 2026-02-04 |
Voll Mark |
Chief Financial Officer |
Unbekannt |
- |
- |
- |
25,000 |
| 2026-01-21 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
10,000 |
$1.00 |
$9.98K |
798,460 |
| 2025-12-31 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
9,795 |
$0.86 |
$8.42K |
788,460 |
| 2025-12-30 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
205 |
$0.83 |
$169.33 |
778,665 |
| 2025-12-18 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
5,000 |
$0.90 |
$4.51K |
340,040 |
| 2025-12-17 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
5,000 |
$0.85 |
$4.26K |
335,040 |
| 2025-12-16 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
12,000 |
$0.85 |
$10.2K |
778,460 |
| 2025-12-05 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
10,000 |
$0.96 |
$9.6K |
766,460 |
| 2025-11-24 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
12,000 |
$0.80 |
$9.6K |
756,460 |
| 2025-11-21 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
10,000 |
$0.80 |
$8K |
744,460 |
| 2025-10-01 |
Ryan Una S |
Director |
RSU-Zuteilung |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-10-01 |
Spiegel Robert J. |
Director |
RSU-Zuteilung |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-10-01 |
Macfarlane K. Angela |
Director |
RSU-Zuteilung |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-10-01 |
Marton Laurence |
Director |
RSU-Zuteilung |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-08-25 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
5,000 |
$0.91 |
$4.55K |
330,040 |
| 2025-08-22 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
5,000 |
$0.95 |
$4.75K |
325,040 |
| 2025-07-01 |
Bagai Shaun |
Chief Executive Officer |
RSU-Zuteilung |
102,498 |
$1.27 |
$130.17K |
102,498 |
| 2025-07-01 |
Agah Ramtin |
Chief Medical Officer |
RSU-Zuteilung |
63,636 |
$1.27 |
$80.82K |
63,636 |
| 2025-07-01 |
Kocak Ron |
VP, Controller and Pao |
RSU-Zuteilung |
41,600 |
$1.27 |
$52.83K |
41,600 |
| 2025-07-01 |
Gentry Leesa |
Chief Clinical Officer |
RSU-Zuteilung |
6,619 |
$1.27 |
$8.41K |
6,619 |
| 2025-06-05 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
21,000 |
$1.40 |
$29.4K |
734,460 |
| 2025-05-02 |
Marton Laurence |
Director |
Optionsausübung (Verkauf) |
20,480 |
$0.15 |
$3.07K |
- |
| 2025-04-22 |
Agah Ramtin |
Chief Medical Officer |
Schenkung (gegeben) |
400,000 |
- |
- |
713,460 |
| 2025-04-15 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
7,500 |
$0.91 |
$6.82K |
320,040 |
| 2025-04-15 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
15,000 |
$0.90 |
$13.5K |
1,113,460 |
| 2025-04-14 |
Bagai Shaun |
Chief Executive Officer |
RSU-Zuteilung |
409,992 |
$0.84 |
$346.36K |
409,992 |
| 2025-04-14 |
Agah Ramtin |
Chief Medical Officer |
RSU-Zuteilung |
254,542 |
$0.84 |
$215.04K |
254,542 |
| 2025-04-14 |
Kocak Ron |
VP, Controller and Pao |
RSU-Zuteilung |
166,400 |
$0.84 |
$140.57K |
166,400 |
| 2025-04-14 |
Gentry Leesa |
Chief Clinical Officer |
RSU-Zuteilung |
26,477 |
$0.84 |
$22.37K |
26,477 |
| 2025-04-11 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
20,000 |
$0.80 |
$16K |
1,098,460 |
| 2025-04-10 |
Kocak Ron |
VP Controller and Pao |
Informierter Kauf |
6,500 |
$0.79 |
$5.14K |
12,595 |
| 2025-04-09 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
10,000 |
$0.83 |
$8.3K |
312,540 |
| 2025-04-09 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
30,000 |
$0.81 |
$24.4K |
1,078,460 |
| 2025-04-09 |
Kocak Ron |
VP Controller and Pao |
Informierter Kauf |
6,000 |
$0.80 |
$4.8K |
6,095 |
| 2025-04-08 |
Marton Laurence |
Director |
Informierter Kauf |
12,050 |
$0.85 |
$10.22K |
45,684 |
| 2025-04-08 |
Agah Ramtin |
Chief Medical Officer |
Informierter Kauf |
26,000 |
$0.84 |
$21.84K |
1,048,460 |
| 2025-04-08 |
Kocak Ron |
VP Controller and Pao |
Informierter Kauf |
95 |
$0.80 |
$76.00 |
95 |
| 2025-04-07 |
Bagai Shaun |
Chief Executive Officer |
Informierter Kauf |
10,000 |
$0.83 |
$8.3K |
302,540 |
| 2024-10-01 |
Ryan Una S |
Director |
RSU-Zuteilung |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-10-01 |
Spiegel Robert J. |
Director |
RSU-Zuteilung |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-10-01 |
Marton Laurence |
Director |
RSU-Zuteilung |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-10-01 |
Macfarlane K. Angela |
Director |
RSU-Zuteilung |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-03-06 |
Gentry Leesa |
Chief Clinical Officer |
RSU-Zuteilung |
190,000 |
$1.69 |
$321.1K |
190,000 |
| 2024-02-09 |
Kocak Ron |
VP, Controller and Pao |
RSU-Zuteilung |
15,000 |
$1.59 |
$23.85K |
15,000 |
| 2024-01-26 |
Spiegel Robert J. |
Director |
Informierter Kauf |
40,983 |
$1.22 |
$50K |
40,983 |
| 2024-01-26 |
Marton Laurence |
Director |
Informierter Kauf |
8,196 |
$1.22 |
$10K |
8,196 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
